A highly transmissible, frequently antimicrobial-resistant species of fungus, Trichophyton indotineae emerged and spread widely throughout parts of South Asia over the last decade. The first cases in the United States were recently confirmed using advanced molecular techniques.
Collaborating organizations across the nation have fostered the rapid release of coronavirus sequence data. These data have been used to guide the COVID-19 public health response, drive innovation and discovery, and advance understanding of this and future pandemics.
In early 2020, CDCs Office of Advanced Molecular Detection (OAMD) launched the Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES) consortium to coordinate SARS-CoV-2 sequencing and help accelerate the use of pathogen sequence data and molecular epidemiology for the pandemic response.
We congratulate Duncan MacCannell PhD, MBT, on the announcement of his new role as director of CDC’s Office of Advanced Molecular Detection, Through his vision and leadership, OAMD will continue to promote capacity, ethical open data, and equity in precision public health. In 2011, Duncan began work on the initiative that, in 2014, became the AMD program. He has guided the program’s development ever since as OAMD’s chief science officer, the position he held before accepting the role as Acting OAMD director, when Greg Armstrong, MD retired in September 2022.